Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Queensland Health
Fish and Richardson
Boehringer Ingelheim

Generated: August 19, 2017

DrugPatentWatch Database Preview

Claims for Patent: ► Subscribe

« Back to Dashboard

Claims for Patent: ► Subscribe

Title: Process for the preparation of a granulate suitable to the preparation of rapidly disintegrable mouth-soluble tablets and compositions obtained thereby
Abstract:A process for making a granulate composition suitable to the preparation of an oral solid form that can disintegrate rapidly inside the buccal cavity is provided as well as the granulate compositions and obtained.
Inventor(s): Bonadeo; Daniele (Varese, IT), Ciccarello; Franco (Via la Loggia Mezzovico, CH), Pagano; Aberto (L'Aquila, IT)
Assignee: Elan Pharma International Limited (Dublin, IE)
Application Number:09/122,037
Patent Claims: 1. A process for making a granulate for use in the preparation of mouth-soluble, rapidly disintegrating tablets, which process comprises:

(i) granulating in a fluidized bed

(a) a polyalcohol;

(b) an active ingredient;

(c) from 1 to 30% of an edible acid wherein the edible acid is not part of an effervescent mixture consisting of an acid and a base;

(d) optionally, other solid components selected from the group consisting of lubricants, sweetening agents, and flavors; and

(e) an aqueous solution or aqueous dispersion of a water-soluble or water-dispersible polymer that provides 1-10% of the final weight of the granulate; and

(ii) drying the granulate in the fluidized bed.

2. A process according to claim 1 in which the water-soluble or water-dispersible polymers are selected from the group consisting of polyethylene glycols, sodium carboxymethyl cellulose, hydroxypropylmethyl cellulose, xanthan gum, polyethylene oxide, polyoxyethylene, polyoxypropylene Pluronic.RTM., acrylic and methacrylic acid polymers Eudragit.RTM., carrageenin, polyvinyl alcohol.

3. A process according to claim 1 in which the polyalcohols are selected from the group consisting of mannitol, xylitol, sorbitol, erythritol, maltitol, lactitol.

4. A process according to claim 3, in which the polyalcohols are selected from the group consisting of xylitol and sorbitol.

5. A process according to claim 4 in which the active ingredients have been coated before the granulation.

6. Mouth-soluble, rapidly disintegrating tablets comprising the granulate of claim 1.

7. Tablets according to claim 6 having a disintegration time ranging from 30 seconds to 3 minutes.

8. A process of making a mouth-soluble, rapidly disintegrating tablet comprising comprising the granulate of claim 1 and optionally, other components to form a tablet.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
US Army
Fish and Richardson
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus